[Favorable outcome of Castleman's disease treated with oral valganciclovir].
Valencia
M Eulalia
ME
Moreno
Victoria
V
Martínez
Pilar
P
Casado
Isabel
I
D000284:Administration, Oral; D000998:Antiviral Agents / Q000627:therapeutic use*; D005871:Castleman Disease / Q000150:complications* / Q000188:drug therapy*; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000150:complications* / Q000188:drug therapy; D019288:Herpesvirus 8, Human; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077562:Valganciclovir
D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir